A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.

Yesterday was a great day to be Rory McIlroy or Shane Lowry—hitting dynamite aces on Spyglass Hill’s No. 15 and Pebble ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

There's something special about biting into a warm, flaky biscuit, but when you add fresh blueberries and a touch of sw ...

Banana bread has been a beloved classic for generations, but what if you could enjoy all its delicious flavors in cooki ...

This king cake is a celebration of the poppy seeds and comes with a Russian nesting doll. Here's how to try it in New Orleans ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Russell Wilson has a chance to turn the 2025 Pro Bowl Games into his own audition, much like Derek Carr did before landing ...